Recombinant multi-species CCN5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCN5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like (CT) domain. The encoded protein lacks the CT domain which is implicated in dimerization and heparin binding. It is 72% identical to the mouse protein at the amino acid level. This gene may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. Its expression in colon tumors is reduced while the other two WISP members are overexpressed in colon tumors. It is expressed at high levels in bone tissue, and may play an important role in modulating bone turnover. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CCN5,CCN family member 5,Connective tissue growth factor-like protein (CTGF-L), Connective tissue growth factor-related protein 58, WNT1-inducible-signaling pathway protein 2 (WISP-2),CT58,WISP2,CTGF-L
Go
to CCN5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0753-Ab-1/ GM-Tg-hg-SE0753-Ab-2 | Human CCN5 protein | Human |
GM-Tg-rg-SE0753-Ab-1/ GM-Tg-rg-SE0753-Ab-2 | Rat CCN5 protein | Rat |
GM-Tg-mg-SE0753-Ab-1/ GM-Tg-mg-SE0753-Ab-2 | Mouse CCN5 protein | Mouse |
GM-Tg-cynog-SE0753-Ab-1/ GM-Tg-cynog-SE0753-Ab-2 | Cynomolgus/Rhesus macaque CCN5 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0753-Ab-1/ GM-Tg-felg-SE0753-Ab-2 | Feline CCN5 protein | Feline |
GM-Tg-cang-SE0753-Ab-1/ GM-Tg-cang-SE0753-Ab-2 | Canine CCN5 protein | Canine |
GM-Tg-bovg-SE0753-Ab-1/ GM-Tg-bovg-SE0753-Ab-2 | Bovine CCN5 protein | Bovine |
GM-Tg-equg-SE0753-Ab-1/ GM-Tg-equg-SE0753-Ab-2 | Equine CCN5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-SE0753-Ab-1/ GM-Tg-hg-SE0753-Ab-2;
GM-Tg-rg-SE0753-Ab-1/ GM-Tg-rg-SE0753-Ab-2;
GM-Tg-mg-SE0753-Ab-1/ GM-Tg-mg-SE0753-Ab-2; GM-Tg-cynog-SE0753-Ab-1/ GM-Tg-cynog-SE0753-Ab-2; GM-Tg-felg-SE0753-Ab-1/ GM-Tg-felg-SE0753-Ab-2; GM-Tg-cang-SE0753-Ab-1/ GM-Tg-cang-SE0753-Ab-2; GM-Tg-bovg-SE0753-Ab-1/ GM-Tg-bovg-SE0753-Ab-2; GM-Tg-equg-SE0753-Ab-1/ GM-Tg-equg-SE0753-Ab-2 |
Products Name | CCN5 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | CCN5 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCN5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.